Dissolution Technologies

Papers
(The median citation count of Dissolution Technologies is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
In Vitro Product Performance Testing of Oral Drug Products: View of the USP Expert Panel9
Evaluation of a pH-Gradient Biphasic Dissolution Test for Predicting In Vivo Performance of Weakly Basic Drugs7
Comparative Analysis of Commercially Available Acetaminophen Tablets in Saudi Arabia5
Predictive Dissolution Models for Real-Time Release Testing: Development and Implementation - Workshop Summary Report4
In Vitro Performance Tests for Continuous Manufacturing: The Impact on the Current Compendial Framework from the Viewpoint of the USP New Advancements in Product Performance Testing Expert Panel4
Evaluation of Critical Quality Attributes of Dapsone Gel4
Comparison of Release Rates Derived from Cutaneous Versus Film-Forming Solution Containing Terbinafine: Approach Towards Qualification and Validation of In Vitro Parameters3
In Vitro Characterization of Multi-Source Omeprazole Capsule Dissolution Performance Under Biorelevant Conditions2
Comparative Study of Metformin Hydrochloride Tablets in Argentina2
Dissolution Profile of Apixaban Tablets: Method Development and Validation Using HPLC Analysis2
A Novel Application of an Effervescent Agent in Naproxen Liqui-Pellets for Enhanced Drug Release2
Questions and Answers May 20232
Simulated Lymphatic Fluid for In-Vitro Assessment in Pharmaceutical Development2
Highlights from 2022 AAPS 360-In Vitro Release and Dissolution Testing Community Annual Meeting2
Review: Application of Bioequivalence Testing of Medicines in Peru1
Dissolution Best Practices and International Harmonization - AAPS Workshop Report1
Comparative Study of Metformin Hydrochloride Tablets in Argentina1
Evaluation of NanoDis as an Automated Sampling Technology for In Vitro Release Testing of Nanomedicines1
Questions and Answers February 20221
Dissolution Performance of Verapamil-HCl Tablets Using USP Apparatus 2 and 4: Prediction of In Vivo Plasma Profiles1
Questions and Answers November 20231
Questions and Answers February 20251
Dissolution Specifications for Ibuprofen Soft Gelatin Capsules: A Proposal1
Factors Influencing the Selection of Medium for Evaluating Drug Solubility and Dissolution in Bovine Milk1
Report on the Virtual Workshop: A Quest for Biowaiver, Including Next Generation Dissolution Characterization and Modeling1
In Vitro Bioequivalence of Acetylsalicylic Acid and Implications in Public Health0
Comparative Study of Brand and Generics Ciprofloxacin Tablets Available in the Saudi Market0
In Vitro Performance of Commercially Available Glimepiride Tablets in Indonesia0
Overview of the Activities of the USP Expert Panel on New Advancements in Product Performance Testing0
Dissolution Method Troubleshooting: An Industry Perspective0
Demonstrating Discriminatory Power of a Dissolution Method Using DDDPlus: Case Study of an Extended-Release Formulation and Use in Regulatory Justifications0
Influence of Storage Conditions on Pharmaceutical Equivalence and Similarity of Hydrochlorothiazide Tablets in Argentina0
Dissolution Test of Patent and Generic Drugs of Metformin Hydrochloride0
Characterization of Apex Vessel Geometries and Irregularities0
The Importance of Dissolution Tests to Evaluate Quality of Dietary Supplements: Case Study of Controlled Release Caffeine Capsules0
Using a Laser Monitoring Technique for Dissolution and Thermodynamic Study of Celecoxib in 2-Propanol and Propylene Glycol Mixtures0
The Combination of Liqui-Mass System and Pelletization to Improve Pharmaceutical Properties of Hydrochlorothiazide0
Highlights from the 2023 AAPS 360 Annual Meeting - In Vitro Release and Dissolution0
Comparison of In Vitro Phosphate-Binding Studies of Sevelamer Carbonate Using Incubator Shaker and USP Dissolution Apparatus II0
Quality Control Parameters of Antihypertensive Medications Marketed in Eastern Ethiopia: Amlodipine Besylate and Enalapril Maleate Tablets0
Questions and Answers August 20220
Questions and Answers May 20240
Magnesium Stearate - Its Importance and Potential Impact on Dissolution of Oral Solid Dosage Forms0
In-Vitro Product Performance of Parenteral Drug Products: View of the USP Expert Panel0
Preparation and Characterization of a Novel Optimum Modified Liquisolid Compact to Enhance the Dissolution Profile of Mifepristone0
Formulation and Evaluation of Bisoprolol Hemifumarate Emulgel for Transdermal Drug Delivery0
Highlights From the 2021 AAPS 360 Annual Meeting0
Testing the In-Vitro Product Performance of Nanomaterial-Based Drug Products: View of the USP Expert Panel0
Advances in Product Quality and Performance Tests for Topical and Transdermal Products: View of the USP Expert Panel0
Selection and Parameters Affecting Dissolution Media0
New USP Dissolution Performance Verification Standard: What, Where, and When0
Development of In Vitro Dissolution Test Method for Bilastine and Montelukast Fixed-Dose Combination Tablets0
Development of a Physiologically Relevant Simulated Nasal Fluid for In Vitro Dissolution Studies0
Life Cycle Application of AQbD for Formulation Development and Validation of a Dissolution Method for Nevirapine0
Biorelevant Dissolution of Dipyridamole and Piroxicam Using an Automated UV/Vis Spectrophotometric and Potentiometric Dissolution Testing Platform0
Pharmaceutical Equivalence of Losartan Potassium Tablets in Argentina0
Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru0
Consistency Evaluation of Dissolution of Granisetron Hydrochloride Tablets in China0
Application of Salicylic Acid Tablets in the Performance Verification Test for the Flow-Through Cell Apparatus0
Comparison of Rosuvastatin Calcium Tablets Marketed in Saudi Arabia Under Biowaiver Conditions: In Vitro Quality Control Dissolution Study0
Dissolution Testing Strategies for Large Sample Sizes and Applications in Continuous Manufacturing0
Comparative Dissolution Study of Various Brands of Valsartan Tablets Marketed in Pakistan0
Book Review: “Analytical Testing for the Pharmaceutical GMP Laboratory”0
An In Vitro Model for Release of Acetaminophen When an Overdose is Ingested Orally0
Hypothetical Plasma Concentration-Time Profiles of Amiodarone-HCl From In Vitro Release Data0
Comparative In Vitro Release of Eletriptan Hydrobromide Formulations for Buccal Administration0
Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets0
Influence of Storage Conditions on the Pantoprazole Dissolution Profile for Gastro-Resistant Tablet Formulations0
Evaluation of Different Methods for Dissolution Profile Similarity Comparison of Montelukast Tablets in Türkiye0
Physicochemical Quality and In Vitro Bioequivalence of Amoxicillin Capsules Marketed in Burkina Faso, Africa0
Testing the In Vitro Product Performance of Mucosal Drug Products: View of the USP Expert Panel0
Improved Melatonin Dissolution Properties: A Way Forward for Treating Children with Sleep Disorders0
Investigation of Dissolution Failures of Metformin Delayed-Release Tablets During Formulation Design0
Questions and Answers August 20230
Dissolution Method Development for Regulatory Approval: A Comprehensive Review and Case Study0
Update on Gastrointestinal Biorelevant Media and Physiologically Relevant Dissolution Conditions0
Comparative Dissolution of Budesonide from Four Commercially Available Products for Oral Administration: Implications for Interchangeablity0
Biorelevant Dissolution Testing of Numerically Optimized Multiparticulate Drug Delivery Systems of Gliclazide0
Virtual Workshop Report: Approaches, Regulatory Challenges, and Advances in Bioequivalence, Dissolution Testing, and Biowaivers: Manila, Philippines, February 22-24, 20230
Comparative Dissolution Study of Atorvastatin Calcium Tabletsin Indonesia0
Questions and Answers November 20220
Mathematical Model Application for In Vitro Release Kinetics of Ranolazine Extended-Release Tablets0
Impact of Vessel Inner Diameter in USP Dissolution Apparatus 20
Testing the In Vitro Product Performance of Inhalation and Nasal Drug Products: Views of the USP Expert Panel0
Comparative Dissolution Study of Enzalutamide Capsules in India0
Release Profile of Branded Atorvastatin Calcium Tablet Relative to Commercially Available Counterpart Generics0
Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets0
Contribution of Multivariate Analysis to the In Vitro Dissolution Profile for Testing Clopidogrel Drugs Similarity0
Biopharmaceutical and Quality Evaluation of Immediate-Release Metformin Hydrochloride Tablets in Brazil0
Predicting Dissolution of Entecavir Using the Noyes Whitney Equation0
Dissolution Profile of Calcium Supplements in Brazil: A Critical Analysis and Formulation Proposal0
Comparative Evaluation of Amlodipine Besylate Generic Tablet and Capsule Brands in Riyadh, Saudi Arabia0
Questions and Answers February 20240
Study of Drug Release Kinetics of Rosuvastatin Calcium Immediate-Release Tablets Marketed in Saudi Arabia0
Effect of Mannitol Particle Size on Melatonin Dissolution and Tablet Properties using a Quality by Design Framework0
Questions and Answers November 20240
Questions and Answers February 20230
Questions and Answers August 20240
0.045487880706787